Hip Osteoarthritis (Coxarthrosis) Grade 3: can it be managed without joint replacement?

Hip osteoarthritis (coxarthrosis) grades 3–4 — a sentence to joint replacement? Not always. Regenerative medicine opens new possibilities for preserving the native joint.

When is joint replacement recommended?

Standard indications for hip joint replacement:

• Hip osteoarthritis III–IV stage per Kellgren-Lawrence
• Persistent pain syndrome unresponsive to conservative treatment
• Significant limitation of mobility
• Reduced quality of life

Problems with joint replacement

Despite high effectiveness, joint replacement has several drawbacks:

• Prosthesis lifespan — 15–20 years, after which revision is required
• Risk of complications — infection (1–2%), dislocation, thrombosis
• Rehabilitation — 3–6 months
• Limitations — prohibition on running, jumping, contact sports

What can MIBRAR® do for hip osteoarthritis grade 3?

Prof. Babayan and the MIBRAR® team have accumulated experience treating over 3,000 patients with hip osteoarthritis, including grade III. Results:

• Pain reduction by 70–85% in most patients
• Improvement in joint mobility by 40–60%
• Delay of joint replacement by 5–10+ years
• In some patients — complete avoidance of joint replacement

The key to success is the combination of CGF + Lipogems®, delivered directly to areas of maximum cartilage damage under precise navigation.

How does MIBRAR® work for hip osteoarthritis?

The hip joint is a deep ball-and-socket joint, difficult to access for injections. MIBRAR® solves this problem:

1. 3D planning — Cyber Navi Hand™ analyzes MRI and identifies points of maximum cartilage damage
2. Precise access — 1.5 mm micropuncture under ultrasound navigation with Sono Control Arm™
3. Dual concentrate — CGF reduces inflammation, Lipogems® initiates chondrogenesis (new cartilage growth)
4. Both joints at once — for bilateral hip osteoarthritis. With joint replacement — only one joint with 3-6 month intervals

Advantages for younger patients

For patients under 55 years, joint replacement is particularly problematic: the prosthesis lasts 15-20 years, after which revision surgery is required — technically more complex with worse outcomes. MIBRAR® allows preserving the native joint and delaying or completely avoiding replacement.

Related Articles